Bio Protocol vs RSS3 — how do they compare? Bio Protocol trades at Rp512.02 (market cap Rp1,15T, Rp256,3M 24h volume), while RSS3 trades at Rp101.77 (market cap Rp82,23M, Rp28,18M 24h volume). The key difference: Bio Protocol is far larger — about 13985.2× RSS3's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 906,2M / 1B RSS3 (91%) for RSS3. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and RSS3 for 18 Days on average.
| BIO | RSS3 | |
|---|---|---|
Market Cap | Rp1,15T | Rp82,23M |
Volume (24h) | Rp256,3M | Rp28,18M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 906,2M / 1B RSS3 (91%) |
Typical Hold Time | 16 Days | 18 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →RSS3 is the Open Information Layer, structuring open information for the next Twitter, Google, and OpenAI. The RSS3 Network is formed by decentralized nodes that consistently index and structure information from the Open Web, ensuring its availability and accessibility for all.
Read more on RSS3 →